alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
#### UNITED STATES of America, Plaintiff—Appellee, v. Jose Antonio NIEVES, a/k/a Antonio Perez, Defendant—Appellant.

No. 03-4626.

United States Court of Appeals, Fourth Circuit.

Submitted April 29, 2004.

Decided May 3, 2004.

David B. Freedman, White & Crumpler, Winston-Salem, North Carolina, for Appellant. Anna Mills Wagoner, United States Attorney, Robert A.J. Lang, Assistant United States Attorney, Winston-Salem, North Carolina, for Appellee.

*139Before LUTTIG, WILLIAMS, and SHEDD, Circuit Judges.

Dismissed by unpublished PER CURIAM opinion.

Unpublished opinions are not binding precedent in this circuit. See Local Rule 36(c).

PER CURIAM:

Jose Antonio Nieves pled guilty to possession of 422.8 grams of cocaine base (crack) with intent to distribute, 21 U.S.C.A. § 841(a), (b)(1)(A) (West 1999 & Supp.2003) (Count One), and to possession of a firearm in furtherance of a drug trafficking crime, 18 U.S.C. § 924(c)(1)(A) (2000). His plea agreement provided that he waived his right to appeal his sentence “on any ground, including any appeal right conferred by Title 18, United States Code, Section 3742(a),” excepting only claims of prosecutorial misconduct, ineffective assistance of counsel, a sentence in excess of the statutory maximum, and a sentence based on an unconstitutional factor. Nieves was sentenced to a term of 235 months imprisonment for the drug offense and a consecutive five-year term for the § 924(c) offense. He now seeks to appeal his sentence, contending that the district court erred in determining the amount of crack for which he was responsible. Based on Nieves’ waiver of his appeal right, we dismiss the appeal.

A defendant may waive his right to appeal if the waiver is knowing and voluntary. *United States v. Brown,*232 F.3d 399, 403 (4th Cir.2000); *United States v. Marin,*961 F.2d 493, 496 (4th Cir.1992). The record here discloses that Nieves’ waiver of his appeal right was knowing and voluntary. He does not claim that any of the exceptions apply.

We therefore dismiss the appeal. We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional process.

*DISMISSED*
<PAGE>

                                                                   Exhibit 99(c)

                             TXU US HOLDINGS COMPANY

                       Certificate Pursuant to Section 906
                         of Sarbanes - Oxley Act of 2002

     The undersigned, Michael J. McNally, Principal Financial Officer of TXU US
Holdings Company (the "Company"), DOES HEREBY CERTIFY that:

     1.   The Company's Quarterly Report on Form 10-Q for the quarter ended
          June 30, 2002 (the "Report") fully complies with the requirements of
          section 13(a) or 15(d) of the Securities Exchange Act of 1934, as
          amended; and

     2.   Information contained in the Report fairly presents, in all material
          respects, the financial condition and results of operation of the
          Company.

     IN WITNESS WHEREOF, the undersigned has caused this instrument to be
executed this 14th day of August, 2002.



                                        ----------------------------------------
                                        Name:  Michael J. McNally
                                        Title: Principal Financial Officer
John Ducker 

President and CEO 

Fresenius Kabi USA, LLC 

Three Corporate Drive 

Lake Zurich, Illinois 60047 

Dear Mr. Ducker: 

The U.S. Food and Drug Administration (FDA) is pleased to announce that Fresenius Kabi USA, LLC 

has been selected to receive a Drug Shortage Assistance Award for its role in preventing or alleviating a 

drug shortage. 

Fresenius Kabi is being recognized for its efforts related to mitigating the shortage ofIV saline, including 

temporary importation oftheir product and ultimately submitting and obtaining approval of an 

abbreviated new drug application ( 2073 10) for Sodium Chloride Injection USP, 0.9%, adding additional 

approved supplies to the U.S. market. 

FDA established this award program to recognize companies for making a substantial contribution to 

preventing or alleviating a drug shortage. FDA hopes this award serves as an incentive for other 

companies to assist in addressing drug shortages, as Fresenius Kabi has done. 

The intent ofthe award program is to recognize manufacturers or companies that assist FDA in 

addressing a drug shortage, for their commitment to public health and -quality manufacturing, a key 

component of the Strategic Plan for Preventing and Mitigating Drug Shortages. More information on the 

strategic plan can be found on FDA 's drug shortages web page 

(http://www.fda. gov/dru gs/drugsafet y/ drugshortages/defaul t.htm). 

FDA thanks Fresenius Kabi for working to mitigate the shortage of Sodium Chloride Injection USP, 

0.9%. The enclosed press release/web statement template is provided to assist you in publicizing your 

award from FDA. 

)?;'·~///) Douglas C. Throckmorton, M.D. 


Deputy Center Director for Regulatory Programs, 


FDA, Center for Drug Evaluation and Research 


Enclosure(s): 

Certificate 

Optional Press Release/Web Statement Template 

cc: Fresenius Kabi USA, LLC 

U.S. Food & Drug Administration 

10903 New Hampshire Avenue 

Silver Spring, MD 20903 

www.fda.gov
Exhibit 44

- Filed Under Seal -

Case 5:17-cv-00551-LHK Document 285-45 Filed 10/18/18 Page 1 of 1
<TABLE> <S> <C>

<PAGE>
 
<ARTICLE> 5
       
<S>                             <C>                     <C>
<PERIOD-TYPE>                   3-MOS                   9-MOS
<FISCAL-YEAR-END>                          FEB-29-1996             FEB-29-1996
<PERIOD-START>                             SEP-01-1995             MAR-01-1995
<PERIOD-END>                               NOV-30-1995             NOV-30-1995
<CASH>                                       1,675,215               1,675,215
<SECURITIES>                                         0                       0
<RECEIVABLES>                                6,508,739               6,508,739
<ALLOWANCES>                                         0                       0
<INVENTORY>                                    651,107                 651,107
<CURRENT-ASSETS>                             9,429,771               9,429,771
<PP&E>                                      15,282,873              15,282,873
<DEPRECIATION>                               8,128,281               8,128,281
<TOTAL-ASSETS>                              17,567,839              17,567,839
<CURRENT-LIABILITIES>                        3,260,968               3,260,968
<BONDS>                                              0                       0
<PREFERRED-MANDATORY>                                0                       0
<PREFERRED>                                          0                       0
<COMMON>                                        82,082                  82,082
<OTHER-SE>                                  14,224,789              14,224,789
<TOTAL-LIABILITY-AND-EQUITY>                17,567,839              17,567,839
<SALES>                                              0                       0
<TOTAL-REVENUES>                             9,012,316              27,340,818
<CGS>                                                0                       0
<TOTAL-COSTS>                                7,147,837              21,548,118
<OTHER-EXPENSES>                                     0                       0
<LOSS-PROVISION>                                     0                       0
<INTEREST-EXPENSE>                                   0                  15,001
<INCOME-PRETAX>                                352,567               1,290,235
<INCOME-TAX>                                    41,000                 154,000
<INCOME-CONTINUING>                            311,567               1,136,235
<DISCONTINUED>                                       0                       0
<EXTRAORDINARY>                                      0                       0
<CHANGES>                                            0                       0
<NET-INCOME>                                   311,567               1,136,235
<EPS-PRIMARY>                                     0.04                    0.14
<EPS-DILUTED>                                     0.04                    0.14
        

</TABLE>
CERTIFICATION
OF CHIEF EXECUTIVE OFFICER PURSUANT TO
 SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
 
 
 
 
 
 
 In connection
with the Annual Report of First Guaranty Bancshares, Inc. (the “Company”) on
Form 10-K for the fiscal year ended December 31, 2007 as filed with the
Securities and Exchange Commission on the date hereof (the “Report”), I, Michael
R. Sharp, President and Chief Executive Officer of the Company, certify that to
the best of my knowledge:
  
 
 
    /s/
      Michael R. SharpMichael
      R. SharpPresident
      and Chief Executive OfficerMarch
      31, 2008
IN THE SUPREME COURT OF PENNSYLVANIA

MIDDLE DISTRICT

JAMES M. MCMASTER AND MARY 

ELLEN MCMASTER, H/W,

Petitioners

v.

THE TOWNSHIP OF BENSALEM,

Respondent

:

:

:

:

:

:

:

:

:

:

:

:

No. 351 MAL 2017

Petition for Allowance of Appeal from 

the Order of the Commonwealth Court

ORDER

PER CURIAM

AND NOW, this 3rd day of October, 2017, the Petition for Allowance of Appeal is 

DENIED.
[Federal Register Volume 60, Number 92 (Friday, May 12, 1995)]
[Notices]
[Pages 25737-25738]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-11790]



-----------------------------------------------------------------------


DEPARTMENT OF THE INTERIOR

Sleeping Bear Dunes National Lakeshore Advisory Commission

AGENCY: National Park Service, Interior.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: This notice sets the schedule for the forthcoming meeting of 
the Sleeping Bear Dunes National Lakeshore Advisory Commission. Notice 
of this meeting is required under the Federal Advisory Committee Act 
(Pub. L. 92-463).

MEETING DATE AND TIME: Friday, July 14, 1995; 9:30 a.m., until 12 noon.

ADDRESSES: Lake Township Hall, 5153 Scenic Drive, Honor, Michigan. The 
agenda for the meeting consists of the Chairman's welcome; minutes of 
the previous meeting; statement of purpose; update on park activities; 
old business; new business; public input; next meeting date; 
adjournment. The meeting is open to the public.

SUPPLEMENTARY INFORMATION: The Advisory Commission was established by 
Pub. L. 91-479. The purpose of the commission, according to its 
charter, is to advise the Secretary of the Interior with respect to 
matters relating to the administration, protection, and development of 
the Sleeping Bear Dunes National Lakeshore, including the establishment 
of zoning by-laws, construction, and administration of scenic roads, 
procurement of land, condemnation of commercial property, and the 
preparation and implementation of the land and water use management 
plan.

FOR FURTHER INFORMATION CONTACT: Ivan Miller, Superintendent, 9922 
Front [[Page 25738]] Street, Empire, Michigan 49630 or telephone 616-
326-5134.

    Dated: May 4, 1995.
William W. Schenk.
Regional Director, Midwest Region.
[FR Doc. 95-11790 Filed 5-11-95; 8:45 am]
BILLING CODE 4310-70-P
# Fourth Court of Appeals

San Antonio, Texas

March 29, 2018

No. 04

- 18

- 00003

- CR

Christine RUSSELL, Appellant

v.

The STATE of Texas, Appellee

From the 25th Judicial District Court, Guadalupe County, Texas

Trial Court No. 11

- 0695

- CR Honorable William Old, Judge Presiding



### O R D E R

On February 8, 2018, the court reporter responsible for preparing the record in this case filed a notification of late record, indicating that the appellant had failed to designate the reporter’s record and had failed to pay the reporter’s record fee or to make arrangements for preparing the reporter’s record. On February 9, 2018, we ordered the appellant to provide written proof that she had filed a designation of record with the court reporter

, and either had paid the reporter’s record fee, had made arrangements to pay the reporter’s record fee, or was entitled to appeal without paying the reporter’s record fee. We further ordered that if the appellant failed to respond within the time provided

, the appellant’s brief w ould be due within thirty days of the

date of our order.

Further review of the clerk’s record shows that the appellant’s court

- appointed counsel was permitted to withdraw from this case on January 2, 2018, and no counsel was appointed in his place. On Ma rch 27, 2018, Gregory Sherwood filed a notice of appearance as appellant’s

court

- appointed counsel on appeal. Mr. Sherwood filed a copy of the trial court’s March 26,

2018 order appointing him as the appellant’s counsel. In its order, the trial court found that appellant is “ too poor to employ counsel ” for her appeal. Mr. Sherwood also filed a copy of a request to the court reporter designating the reporter’s record on appeal.

The appellant was without the benefit of counsel at the time we issued our Febr uary 9

, 2018 order. We, therefore

, WITHDRAW the portion of our February 9 , 2018 order stating that

the appellant’s brief would due in the absence of proof that she had filed a d esignation of record

with in fourteen days of this order.Additionally, i n lig ht of the trial court’s March 26, 2018 finding that the appellant is too

poor to appoint counsel in this appeal , we conclude that the appellant is entitled to appeal without paying the filing fee for the reporter’s record. We ORDER the court reporter to fi le the reporter’s record on or before April 27, 2018

. The appellant’s brief will be due thirty days after the reporter’s record is filed.

_________________________________ Karen Angelini, Justice

IN WITNESS WHEREOF, I have hereunto set my hand and affixed the seal of the said

court on this 29th day of March, 2018

.

___________________________________ KEITH E. HOTTLE

, Clerk of Court
MISSISSIPPI STATE CONFERENCE OF the NATIONAL ASSOCIATION FOR THE ADVANCEMENT OF COLORED PEOPLE, et al., appellants, v. Phil BRYANT, Governor of Mississippi, et al.

No. 12-1019.

Supreme Court of the United States

May 20, 2013.

*2390On Appeal from the United States District Court for the Southern District of Mississippi. Judgment Affirmed.
Roberto Alberto CEPERO, petitioner, v. FLORIDA.

No. 12-8162.

Supreme Court of the United States

April 15, 2013.

Petition for writ of certiorari to the District Court of Appeal of Florida, Fourth District, denied.
SỨC KHỎE 

TIM MẠCH

Bạn có thể nghĩ rằng bệnh tim chỉ ảnh hưởng 

đến nam giới. Điều này không đúng. Bệnh tim là 

nguyên nhân gây tử vong hàng đầu cho phụ nữ. 

Cơ quan Quản Lý Thực Phẩm và Dược Phẩm Hoa 

Kỳ (FDA) có những lời khuyên giúp bạn chọn 

quyết định tốt cho tim của bạn.

Văn Phòng Sức Khỏe Phụ Nữ của FDA

www.fda.gov/womenshearthealth 

Những điều cần biết về 

aspirin.

Dùng aspirin hằng ngày để ngừa nhồi máu cơ 

tim hoặc tai biến mạch máu não không phải 

lúc nào cũng hiệu quả cho tất cả mọi người. 

• Hãy hỏi bác sĩ xem bạn có nên dùng aspirin không.

• Nếu aspirin tốt cho bạn, hỏi xem:

 ‐Bạn nên dùng bao nhiêu.

 ‐Bạn nên dùng nó bao lâu một lần.

 ‐Bạn nên dùng aspirin trong bao lâu. Một số 

thuốc kết hợp aspirin với các chất khác dùng 

lâu dài không tốt.

• Cho bác sĩ biết tất cả các loại thuốc bệnh và thuốc 

bổ sung bạn đang dùng. Nguy cơ chảy máu có thể 

cao hơn nếu bạn dùng aspirin chung với một số 

thuốc khác, vitamin, hoặc dược thảo.

Nhận ra những dấu 

hiệu khi bị lên cơn đau 

tim.

Các dấu hiệu bị lên cơn đau tim của phụ nữ 

có thể khác với nam giới.

• Đau tức nơi ngực hoặc sau lưng, giữa hai xương 

bả vai

• Đau nhói ở phần trên cơ thể của bạn

• Khó thở

• Toát mồ hôi lạnh

• Mệt mỏi bất thường hoặc không rõ nguyên nhân

• Chóng mặt hoặc choáng váng

• Cảm thấy bao tử khó chịu
SỨC KHỎE 

TIM MẠCH

Muốn biết thêm về sức khỏe tim mạch cho phụ nữ, xin vào trang mạng của,

Cơ quan Quản Lý Thực Phẩm và Dược Phẩm Hoa Kỳ (FDA):

www.fda.gov/womenshearthealth

Quản lý tình trạng 

sức khỏe của bạn.

Các vấn đề sức khỏe phổ biến như 

áp huyết cao, tiểu đường, và cholesterol cao (chất mỡ trong máu) có 

thể làm tăng nguy cơ mắc bệnh tim. 

• Dùng thuốc theo chỉ dẫn. Tiếp tục dùng

thuốc cho đến khi bác sĩ bảo ngưng.

• Nếu bạn bị tiểu đường, hãy kiểm tra 

mức đường trong máu. 

• Xét nghiệm huyết áp và cholesterol. 

• Hỏi bác sĩ cách chăm sóc sức khỏe 

trong thời gian mang thai.

• Một số phụ nữ cần có máy trợ tim. Bàn 

với bác sĩ máy nào tốt nhất cho vấn đề 

tim mạch của bạn.

2016

Cách ăn uống lành 

mạnh cho tim.

Các thành phần dinh dưỡng ghi nơi 

nhãn thực phẩm có thể giúp bạn 

chọn thực phẩm lành mạnh.

• Chọn thực phẩm “low salt” (ít muối) 

hoặc “low sodium” (ít muối hóa học).

• Hạn chế các thực phẩm có “trans fat” 

(chất mỡ). Quá nhiều chất này có thể 

gây nhồi máu cơ tim.

• Giảm đường. Đường còn được ghi 

trên nhãn là “glucose,”“ fructose,” 

“sucrose,” và “ corn syrup.”

SỨC KHỎE TIM MẠCH (VIETNAMESE)
EX-31 Rule 13a-14(d)/15d-14(d) Certification.

  Banc of America Funding Corporation
  Mortgage Pass-Through Certificates,
  Series 2007-7

  I, Kelly Rentz, a Vice President of Wells Fargo Bank, N.A. (the "Master
  Servicer"), certify that:

  1.I have reviewed this report on Form 10-K and all reports on Form 10-D
    required to be filed in respect of the period covered by this report on
    Form 10-K of the Banc of America Funding 2007-7 Trust (the "Exchange
    Act Periodic Reports");

  2.Based on my knowledge, the Exchange Act Periodic Reports, taken as a
    whole, do not contain any untrue statement of a material fact or omit
    to state a material fact necessary to make the statements made, in
    light of the circumstances under which such statements
    were made, not misleading with respect to the period covered by this
    report;

  3.Based on my knowledge, all of the distribution, servicing and other
    information required to be provided under Form 10-D for the period
    covered by this report is included in the Exchange Act Periodic Reports;

  4.I am responsible for reviewing the activities performed by the
    servicers and based on my knowledge and the compliance reviews
    conducted in preparing the servicer compliance statements required in
    this report under Item 1123 of Regulation AB, and except as disclosed
    in the Exchange Act Periodic Reports, the servicers have fulfilled
    their obligations under the servicing agreements in all material
    respects; and

  5.All of the reports on assessment of compliance with the servicing
    criteria for asset-backed securities and their related attestation
    reports on assessment of compliance with servicing criteria for
    asset-backed securities required to be included in this report in
    accordance with Item 1122 of Regulation AB and Exchange Act Rules
    13a-18 and 15d-18 have been included as an exhibit to this report,
    except as otherwise disclosed in this report. Any material instances of
    noncompliance described in such reports have been disclosed in this
    report on Form 10-K.

    In giving the certifications above, I have reasonably relied on
    information provided to me by the following unaffiliated parties: Bank
    of America, National Association as Servicer, SunTrust Mortgage, Inc.
    as Servicer and Washington Mutual Bank as Servicer.

    Dated:   March 27, 2008


    /s/ Kelly Rentz
    Signature

    Vice President
    (senior officer in charge of the servicing function of the master
    servicer)
David Ernest MCELREATH, Appellant, v. STATE of Florida, Appellee.

Case No. 5D18-2351

District Court of Appeal of Florida, Fifth District.

Decision filed July 2, 2019

**DECISION WITHOUT PUBLISHED OPINION**

AFFIRMED.
Order entered December 22 , 2015

In The 

## Court of Appeals Fifth District of Texas at Dallas

No. 05
- 15
- 00938
- CR No. 05
- 15
- 00939
- CR
DEMARCUS JERMANE SAM PSON, Appellant

V. THE STATE OF TEXAS, Appellee On Appeal from the Criminal District Court No. 5

Da llas County, Texas Trial Court Cause No s . F09
- 12092
- L , F09
- 12093
- L



### O RDER Appellant has informed the Court that he wishes to file a pro se response to the Anders brief filed by appellate counsel. Accordingly, we ORDER appellate counsel John Tatum to
pro vide appellant with copies of the clerk’s and reporter’s records. We further ORDER appellate counsel to provide this Court, within THIRTY DAYS of the date of this order, with written verification that the record has been sent to appellant. Appellant’s pr o se response is due by MARCH 4, 2016

. We DIRECT the Clerk to send copies of this order to the Honorable Carter Thompson, Presiding Judge, Criminal District Court No. 5; Victoria Franklin, official court reporter,Criminal District Court No. 5; Felicia Pi tre, Dallas County District Clerk; John Tatum; and the

Dallas County District Attorney’s Office.
We further DIRECT the Clerk to send a copy of this order to Demarcus Sampson, No. 13049333, Dallas County Jail, P.O. Box 660334, Dallas, Texas 75266

- 0334.
/s/ ADA BROWN JUSTICE
1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

United States District Court

Northern District of California

UNITED STATES DISTRICT COURT

NORTHERN DISTRICT OF CALIFORNIA

WAYMO LLC,

Plaintiff,

v.

UBER TECHNOLOGIES, INC., et al.,

Defendants.

Case No.17-cv-00939-WHA (JSC)

ORDER SETTING DISCOVERY 

HEARING

Waymo claims Uber waived the attorney-client privilege with respect to certain subjects 

during Travis Kalanick’s deposition. Uber disputes that the testimony provided was privileged. 

The Court will hear oral argument on that motion, and any other submitted and not yet decided 

discovery motions, at 9:00 a.m. on Wednesday, August 9, 2017.

IT IS SO ORDERED.

Dated: August 7, 2017

JACQUELINE SCOTT CORLEY

United States Magistrate Judge
## COURT OF APPEALS

SECOND DISTRICT OF TEXAS

FORT WORTH

NO. 02

- 14

- 00393

- CV

GLORIA MORENO AND GE NARO

MORENO, JR. APPELLANTS

V.

T

- UNIVERSAL CORP. APPELLEE

------------

FROM THE 153RD DISTR ICT COURT OF TARRANT COUNTY

TRIAL COURT NO. 153

- 267739

- 13

------------



### MEMORANDUM OPINION 1 

### AND JUDGMENT

------------

We have considered appellant s ’ “Motion To Dismiss Appeal.” It is the

court ’ s opinion that the motion should be granted; therefore, we dismiss the

appeal. See Tex. R. App. P. 42.1(a)(1), 43.2( f).

1 See Tex. R. App. P. 47.4.2

Costs of the appeal shall be paid by appellant s , for which let execution

issue. See Tex. R. App. P. 42.1(d).

PER CURIAM

PANEL: MEIER, GABRIEL, and SUDDERTH, JJ.

DELIVERED: February 5, 2015